Last update 01 Nov 2024

Feliqs Corp.

Holding Company|
2019|
Osaka-fu, Japan
|
www.feliqs.co.jp

Overview

Tags

Congenital Disorders
Eye Diseases
Cardiovascular Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
ADRA2(Adrenergic receptors alpha-2)1

Related

2
Drugs associated with Feliqs Corp.
Methyldopa
Target
ADRA2
Mechanism
ADRA2 agonists
Active Org.
Feliqs Corp. [+2]
Originator Org.
Merck Sharp & Dohme Corp.Merck Sharp & Dohme Corp.
Active Indication
Hypertension [+1]
Inactive Indication
Diabetes Mellitus, Type 1
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date20 Dec 1962
FLQ-104
Target-
Mechanism-
Active Org.
Feliqs Corp.
Originator Org.
Feliqs Corp.
Active Indication
Geographic Atrophy [+1]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Feliqs Corp.
Login to view more data
0 Patents (Medical) associated with Feliqs Corp.
Login to view more data
100 Deals associated with Feliqs Corp.
Login to view more data
100 Translational Medicine associated with Feliqs Corp.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
Phase 2 Clinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Methyldopa
 ( ADRA2 )		Retinopathy of Prematurity
More
Phase 2 Clinical
FLQ-104
Wet age-related macular degeneration
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free